Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China.

Volume: 109, Issue: 5, Pages: 531 - 538
Published: Mar 11, 2020
Abstract
Studies have reminded that cardiovascular metabolic comorbidities made patients more susceptible to suffer 2019 novel corona virus (2019-nCoV) disease (COVID-19), and exacerbated the infection. The aim of this analysis is to determine the association of cardiovascular metabolic diseases with the development of COVID-19. A meta-analysis of eligible studies that summarized the prevalence of cardiovascular metabolic diseases in COVID-19 and...
Paper Details
Title
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China.
Published Date
Mar 11, 2020
Volume
109
Issue
5
Pages
531 - 538
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.